PMID- 3068597 OWN - NLM STAT- MEDLINE DCOM- 19890417 LR - 20180217 IS - 0030-3755 (Print) IS - 0030-3755 (Linking) VI - 197 IP - 4 DP - 1988 TI - Clinical application of epiderm growth factor in patients with most severe eye burns. PG - 179-84 AB - 20 eyes of 11 patients suffering from most severe eye burns of grade 4 or worse were treated in addition to various other drugs with epiderm growth factor (EGF) or placebo in a double-blind test. Among 10 eyes treated with EGF, 6 achieved complete regeneration of the corneal epithelium, and 1 additional case, of the conjunctival epithelium. Among the eyes receiving placebo, only 3 out of 10 healed; all of them were also treated with fibronectin. Although in these very difficult cases EGF could not be investigated as a single therapy, and various other undefined factors may have been effective, in the extended course of the disease the period of EGF treatment was marked by a significant better regeneration of the epithelium. FAU - Reim, M AU - Reim M AD - Abteilung Augenheikunde, Medizinische Fakultat, Rheinisch-Westfalische Technische Hochschule Aachen. FAU - Kehrer, T AU - Kehrer T FAU - Lund, M AU - Lund M LA - eng PT - Clinical Trial PT - Comparative Study PT - Controlled Clinical Trial PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Switzerland TA - Ophthalmologica JT - Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde JID - 0054655 RN - 0 (Fibronectins) RN - 62229-50-9 (Epidermal Growth Factor) SB - IM MH - Burns, Chemical/drug therapy MH - Clinical Trials as Topic MH - Double-Blind Method MH - Epidermal Growth Factor/*therapeutic use MH - Eye Burns/*drug therapy MH - Fibronectins/therapeutic use MH - Humans EDAT- 1988/01/01 00:00 MHDA- 1988/01/01 00:01 CRDT- 1988/01/01 00:00 PHST- 1988/01/01 00:00 [pubmed] PHST- 1988/01/01 00:01 [medline] PHST- 1988/01/01 00:00 [entrez] AID - 10.1159/000309941 [doi] PST - ppublish SO - Ophthalmologica. 1988;197(4):179-84. doi: 10.1159/000309941.